1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsTranslational Blood Science and Resources is sponsored by National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
# Translational Blood Science and Resources | NHLBI, NIH A **. gov** website belongs to an official government organization in the United States.
* Education Programs and Initiatives * Learn More Breathe Better® * Blood Diseases & Disorders Education Program * Publications and Resources * Clinical Trials and Studies * Blood Disorders and Blood Safety * Sleep Science and Sleep Disorders * Heart and Vascular Diseases * Precision Medicine Activities * Obesity, Nutrition, and Physical Activity * Population and Epidemiology Studies * Grants and Training Home * Policies and Guidelines * Training and Career Development * Mission and Strategic Vision * Divisions, Offices and Centers * Budget and Legislative Information * Jobs and Working at the NHLBI * NIH Sleep Research Plan * Translational Blood Science and Resources # Translational Blood Science and Resources Funding that supports the creation of blood-focused therapeutics development and manufacturing, the facilitation and promotion of discovery science from bench to first-in-human studies, and the coordination of workforce development and opportunities for small-business programs.
Andrei Kindzelski, MD, PhD Branch Chief: Classical hematology, transfusion, thrombosis, hemostasis kindzelskial@nhlbi. nih. gov mailto:(link sends e-mail) Crystal Hill-Pryor, PhD, MPH Thrombosis; hemostasis; vascular biology, and blood substitutes hillpryorc2@nih.
gov mailto:(link sends e-mail) Coagulation, bleeding disorders, vascular biology, transfusion leslie. neidert@nih. gov mailto:(link sends e-mail) Wound healing, angiogenesis, cell adhesion, Immunology, cell biology deborah.
philp@nih. gov mailto:(link sends e-mail) juan. salomon@nih.
gov mailto:(link sends e-mail) Cellular therapies; immunobiology lis. welniak@nih. gov mailto:(link sends e-mail) Gene therapy, hematopoietic stem cells, lentivirus, ex-vivo transduction idalia.
yabe@nih. gov mailto:(link sends e-mail) The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional) * Freedom of Information Act (FOIA) Related Government Websites * Health and Human Services(link is external) * National Institutes of Health Live Chat with us, Monday through Friday, 8:30 a. m.
to 5:00 p. m. EST.
Receive automatic alerts about NHLBI related news and highlights from across the Institute. External Web Site Policy Close
According to the current listing, eligibility includes: Nonprofits, Universities, State/local governments, Small businesses, For-profit organizations. Confirm the full requirements in the official notice before applying.
Translational Blood Science and Resources is funded by National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) is sponsored by National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH). This funding opportunity invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications. The purpose is to engage small businesses in developing technologies and products that engage, empower, and motivate individuals and communities, including providers and healthcare institutions, to improve minority health and eliminate health disparities. This can include mobile health and telehealth technologies, and promoting big data science or enhancing data scientist training to address health inequities.
NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) is sponsored by National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH). Provides funding to small businesses to bridge the gap between Phase II and commercialization for heart, lung, blood, and sleep disorder technologies.
Five NHLBI Catalyze Product Definition RFAs — HL-26-016 through HL-26-020 — carry an October 21, 2026 receipt date, budget caps of $300,000 to $400,000 per year, and roughly 8 new awards annually. The science is not the gate. An Accelerator Partner and a 0.25:1 non-federal cost match are, and both take longer to line up than the nine weeks you have left.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article